Current Report Filing (8-k)

Date : 10/09/2018 @ 10:17PM
Source : Edgar (US Regulatory)
Stock : Heyu Biological Technology Corporation (HYBT)
Quote : 0.0248  0.0142 (133.96%) @ 9:15PM

Current Report Filing (8-k)

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K  

 

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): October 9, 2018 ( October 4, 2018)

 

 

 

Heyu Biological Technology Corporation

(Exact Name of Registrant as Specified in its Charter)

 

Nevada

 

 

000-26731  

 

 

87-0627910  

(State or Other Jurisdiction of
Incorporation)

 

 

(Commission
 File Number)

 

 

(IRS Employer
Identification Number) 

   

4th Floor, No. 10 Building, Xinglin Bay Business Operation Center,

Jimei District, Xiamen City,

Fujian Province, China 361022

(Address of Principal Executive Offices, Zip Code)

 

Registrant’s telephone number, including area code: (86) 158 5924 0902

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

   

 

  

Item 8.01 Other Events.

 

On October 4, 2018, the Board of Directors (the “Board”) of Heyu Biological Technology Corporation (the “Company”) decided to engage in a series of preliminary mergers and acquisitions negotiations under the belief that the best way to develop the company will be through a merger with, or acquisition of, a business already operating in the bio-technology industry. The Company identified several target companies and the Board is currently evaluating these targets but the Company does not yet have an agreement or arrangement to enter into any such merger or acquisition.

 

  1  

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

    

  Heyu Biological Technology Corporation
   
  By:  /s/ Ban Siong Ang
 

Name:

Title:

Ban Siong Ang
Chief Executive Officer
     
     
  Dated: October 9, 2018

 

  2  

Heyu Biological Technology (USOTC:HYBT)
Historical Stock Chart

1 Year : From Jul 2018 to Jul 2019

Click Here for more Heyu Biological Technology Charts.

Heyu Biological Technology (USOTC:HYBT)
Intraday Stock Chart

Today : Tuesday 16 July 2019

Click Here for more Heyu Biological Technology Charts.

Latest HYBT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.